Marlowe plc acquires Cylix Limited for an enterprise value of £1 million

LONDON: Marlowe plc (LON: MRL), the UK leader in business critical services and software which assure safety and regulatory compliance, has acquired eLearning software platform Cylix Limited (Cylix) for an enterprise value of £1 million.

Cylix, established in 2002, is based in Bath and provides accredited equality, diversity, wellbeing and health & safety eLearning courses to companies across the UK. The acquisition broadens Marlowe’s eLearning offering and will offer attractive synergies with Deltanet, our recently-acquired compliance & safety eLearning platform.

For the year ended 31 January 2021, Cylix generated an operating profit of £0.3 million on revenues of £1.0 million. Net assets at 31 January 2021 were £0.5 million. The acquisition will be funded from Marlowe’s existing cash resources.

Marlowe is a UK leader in business critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services.

It is focused on health & safety, compliance software, employment law & HR compliance, fire safety, security, water treatment & air hygiene and occupational health services – all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation.

Marlowe currently provides services to over 15% of Britain’s commercial premises and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated compliance and safety services.

The customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

Marlowe PLC

783.65 GBX +11.65 (1.51%)

21 May, 4:30 pm GMT+1 · Disclaimer


About the author

Leave a Reply

Your email address will not be published. Required fields are marked *